Intraarticular Ankaferd blood stopper application increases cartilage degeneration: an experimental study

Intraarticular Ankaferd blood stopper application increases cartilage degeneration: an experimental study

Background/aim: Ankaferd blood stopper (ABS) is a mixture of certain ratios of 5 different plant roots (Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica). The aim of this study is to evaluate the histopathological effects of ABS on articular cartilage in vitro. Materials and methods: Twenty-one albino Sprague Dawley rats were randomly allocated to 3 groups: 0.1 mL of saline was injected in the first group, 0.1 mL of ABS was injected in the second group, and 0.1 mL of blood and 0.1 mL of ABS were injected in the third group. One month later all rats were sacrificed. Specimens were obtained for histopathological evaluation. Results: Significant results were detected in the groups with respect to International Cartilage Repair Society and synovial proliferation scores (P < 0.05 and P < 0.01). According to inflammatory cell infiltration and fibrin formation scores, there was no significant difference between group 1 and group 2 (P < 0.01), although there was significant difference between group 3 and the other groups (P > 0.05). Conclusion: ABS and hemarthrosis had toxic effects on knee cartilage. The side effects were increased with the combination of hemarthrosis and ABS. As a result, ABS had unexpected effects on experimental hemarthrosis.

___

  • 1. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163–170.
  • 2. Cömert M, Karakaya K, Barut F, Çakmak GK, Ucan HB, Gültekin FA, Emre AU, Taşçılar O, Irkörücü O, Ankaralı H. Does intraabdominal use of Ankaferd Blood Stopper cause increased intraperitoneal adhesions? Ulusal Travma Acil Cerrahi Derg 2010; 16: 383–389.
  • 3. İşler SC, Demircan S, Cakarer S, Cebi Z, Keskin C, Soluk M, Yüzbaşıoğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409–414.
  • 4. Kurt M, Onal I, Akdogan M, Kekilli M, Arhan M, Sayilir A, Oztas E, Haznedaroglu I. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol 2010; 24: 380–384.
  • 5. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol 2010; 267: 1377–1381.
  • 6. Lee SJ, Umano K, Shibamoto T, Lee KG. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem 2005; 91: 131–137.
  • 7. Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharideactivated macrophages and the structural requirements of diarylheptanoids for the activity. Bioorgan Med Chem 2006; 14: 138–142.
  • 8. Sheela ML, Ramakrishna MK, Salimath BP. Angiogenic and proliferative effects of the cytokine VEGF in Ehrlich ascites tumor cells is inhibited by Glycyrrhiza glabra. Int Immunopharmacol 2006; 6: 494–498.
  • 9. Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A. Synovectomy with rifampicine in haemophilic haemarthrosis. Haemophilia 2000; 6: 562–565.
  • 10. van Meegeren MER, Roosendaal G, Coeleveld K, Nieuwenhuizen L, Mastbergen SC, Lafeber FP. A single intraarticular injection with IL-4 plus IL-10 ameliorates bloodinduced cartilage degeneration in haemophilic mice. Brit J Haematol 2013; 160: 515–520.
  • 11. Ravanbod R, Torkaman G, Esteki A. Comparison between pulsed ultrasound and low level laser therapy on experimental haemarthrosis. Haemophilia 2013; 19: 420–425.
  • 12. Haznedaroglu BZ, Haznedaroglu IC, Walker SL, Bilgili H, Goker H, Kosar A, Aktas A, Captug O, Kurt M, Özdemir Ö et al. Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper. Clin Appl Thromb-Hem 2010; 16: 446–454.
  • 13. Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartilage 2006; 14: 13–29.
  • 14. Kurt M, Oztas E, Kuran S, Onal IK, Kekili M, Haznedaroglu IC. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med 2009; 27: 631–632.
  • 15. Teker AM, Korkut AY, Gedikli O, Kahya V. Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy. Int J Pediatr Otorhi 2009; 73: 1742– 1745.
  • 16. Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy 2008; 40: E262.
  • 17. Waldenberger P, Chemelli A, Hennerbichler A, Wick M, Freund MC, Jaschke W, Thaler M, Chemelli-Steingruber IE. Transarterial embolization for the management of hemarthrosis of the knee. Eur J Radiol 2012; 81: 2737–2740.
  • 18. Jansen NW, Roosendaal G, Lafeber FP. Understanding haemophilic arthropathy: an exploration of current open issues. Brit J Haematol 2008; 143: 632–640.
  • 19. Parsons JR, Zingler BM, McKeon JJ. Mechanical and histological studies of acute joint hemorrhage. Orthopedics 1987; 10: 1019–1026.
  • 20. Okumuş M, Yüksel KZ, Özbağ D, Çıralık H, Yılmaz Z, Gümüşalan Y, Bakan V, Kalender AM. Medicinal plant extract (Ankaferd Blood Stopper) application in deep tissue injuries in rats: histopathological investigation of the effect on regional and systemic tissues. Ulus Travma Acil Cerrahi Derg 2013; 19: 1–7.
  • 21. Odabaş ME, Ertürk M, Çınar C, Tüzüner T, Tulunoğlu Ö. Cytotoxicity of a new hemostatic agent on human pulp fibroblast in vitro. Med Oral Patol Oral 2011; 16: 584–587.
  • 22. Beyazit Y, Kurt M, Kekilli M, Goker H, Haznedaroglu IC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev 2010; 15: 329–336.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Ya Hong YUAN, Chun Fang ZHOU, Zhi Yong LU, Xiao Li WANG, Yan DING, Dongsheng LI

The utility of EBUS-TBNA in mediastinal or hilar lymph node evaluation in extrapulmonary malignancy

Serhat EROL, Serir ÖZKAN, Ceyda Mahleç ANAR, Onur Fevzi ERER

Melih YÜKSEL, Murat PEKDEMİR, Serkan YILMAZ, Elif YAKA, Asli Gülfer KARTAL

Nihal ÖZKAYAR, Fatma AKYEL, Ayşe Nurdan BARÇA, Serhan Vahit PİŞKİNPAŞA, Turan TURHAN, İhsan ATEŞ, Fatih DEDE

Gordana KOVACEVIC, Natasa NIKOLIC, Aleksandra JOVANOVIC-GALOVIC, İvana HRNJAKOVIC-CVJETKOVIC, Dusan VULETA, Aleksandra PATIC, Jelena RADOVANOV, Vesna MILOSEVIC

Recurrent dilatation in resistant benign esophageal strictures: timing is significant

Ahmet BAŞOĞLU, Ayşen TASLAK ŞENGÜL, Yasemin BİLGİN BÜYÜKKARABACAK, Mehmet Gökhan PİRZİRENLİ

Evaluation of new multiplex PCR primers for the identification of Plasmodium species found in Sabah, Malaysia

Cheronie Shely STANIS, Beng Kah SONG, Tock Hing CHUA, Yee Ling LAU, Jenarun JELIP

Mucormycosis: a 10-year experience at a tertiary care center in Turkey

Aslıhan ULU, Ayşe Seza İNAL, Behice KURTARAN, Aysun UĞUZ, Yeşim TAŞOVA, Süheyla KÖMÜR, Hasan Salih Zeki AKSU

Zühal Özen TUNAY, Özdemir ÖZDEMİR, Damla Ergintürk ACAR, İkbal Seza PETRİÇLİ, Şerife Suna OĞUZ

Quantitative comparison of immunohistochemical and PCR analysis of midkine expression in breast cancer types and serum midkine level

Ergün ERDEM, Sevgi ÖZKAN, Yaşar ENLİ, Emre TEPELİ, Metin AKBULUT, Hülya ÇETİN SORKUN